2026 ReGRoW supports underresourced researchers in low and lower-middle income countries to test repurposed therapies for unsolved diseases, seeking affordable treatments and stronger local research capacity.
Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing existing therapies for unsolved diseases in underserved groups, children, rare disease patients, and military groups.
The Donaghue Foundation's R3 grant helps researchers scale and implement proven health interventions in real-world settings, supporting expert guidance and activities to maximize real-world impact.
Early Career in Supportive Care Program supports early-career investigators worldwide conducting clinical trials in cancer supportive care to improve quality of life for patients and caregivers.
Clinical Cancer Research supports investigators conducting patient-centered cancer trials and early-detection studies to improve treatment options, enable earlier intervention, and enhance quality of life.
Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.